Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novavax Stock Is Jumping Today

TheMotleyFool

0 0

Shares of Novavax (NASDAQ: NVAX) were 6.3% higher as of 10:56 a.m. EST on Monday after rising as much as 9.7% earlier in the day. This nice gain came after the biotech updated the progress of its COVID-19 vaccine development before the market opened.

Novavax stated that its late-stage study in the U.K. and its phase 2b study in South Africa of coronavirus vaccine candidate NVX-CoV2373 had completed enrollment. The company also said that its U.S./Mexico late-stage study is "expected to begin in the coming weeks." Novavax had previously stated this study would begin in November.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share